Transurethral resection (TUR) of bladder tumours is not only mandatory for adequate staging but also crucial in delaying or preventing tumour recurrence and progression.
This is the first study to show:
The positive impact of routine second TUR (sTUR) on the long-term outcome of patients with newly diagnosed pT1 bladder cancer (BCa) with respect to the recurrence rate, time to recurrence, progression rate, and disease-specific mortality in a prospective, randomised trial.
Copyright © 